Kelly Chiang led a panel discussion with our clinicians, Dr. Robert Laitman and Hannah Bock, to better understand Serious Mental Illness (SMI), and get their perspectives on treatment and hope. Our core message: we have a proven model that leads to meaningful recovery for those with schizophrenia, bipolar 1, and related psychotic disorders.
About the panelists:
Dr. Robert Laitman is the Clinical Director at Doro Mind, marathon runner, founder of Team Daniel (sponsored the film Into the Light), and published author (Meaningful Recovery from Schizophrenia & Serious Mental Illness with Clozapine). He is a fierce advocate who applies specialized knowledge, including the optimal use of clozapine, to raise the bar on treatment and family advocacy after navigating the system with his son.
Hannah Bock is the Associate Clinical Director at Doro Mind. Hannah brings front-line expertise from Rikers, Bellevue and NYC shelters, and leverages her background in tech to build sustainable, innovative support systems for marginalized populations
The research and clinical data they presented during the discussion underscore both a critical gap in standard care and a powerful opportunity for genuine recovery.
Key Insights from the discussion
The Power of Clozapine: Most effective antipsychotic, and the only FDA-indicated medication for suicide prevention (reducing risk by ~85%).
Proof in the Protocol: 70%+ of schizophrenia patients under our care achieve meaningful recovery vs. the 14% national average.
Family and caregiver advocacy is a key differentiator in successful treatment outcomes.
Recovery is long-term (slow): Patience and a long-term outlook are required. Meaningful recovery is a process, not an immediate event.
Let's continue to make meaningful recovery the new norm.
A huge thank you to the 150+ attendees who joined us virtually and in NYC. Your participation drives awareness and hope. Check out the video below to watch the full panel.